BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15540524)

  • 1. Acute renal failure resulting from intravenous immunoglobulin therapy.
    Wajanaponsan N; Cheng SF
    Hawaii Med J; 2004 Sep; 63(9):266-7. PubMed ID: 15540524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute renal failure following treatment with intravenously administered immunoglobulins].
    van Zanten AR; Beekhuyzen M; van der Meer YG; de Gooijer A; Feith GW
    Ned Tijdschr Geneeskd; 2003 Feb; 147(7):307-10. PubMed ID: 12622009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute renal failure, translocational hyponatremia and hyperkalemia following intravenous immunoglobulin therapy.
    Daphnis E; Stylianou K; Alexandrakis M; Xylouri I; Vardaki E; Stratigis S; Kyriazis J
    Nephron Clin Pract; 2007; 106(4):c143-8. PubMed ID: 17596722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute renal failure and intravenous immune globulin: occurs with sucrose-stabilized, but not with D-sorbitol-stabilized, formulation.
    Chapman SA; Gilkerson KL; Davin TD; Pritzker MR
    Ann Pharmacother; 2004 Dec; 38(12):2059-67. PubMed ID: 15536143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin induced-nephropathy: a complication of IVIG therapy.
    Ahsan N
    J Nephrol; 1998; 11(3):157-61. PubMed ID: 9650125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute renal failure in a pediatric kidney allograft recipient treated with intravenous immunoglobulin for parvovirus B19 induced pure red cell aplasia.
    Subtirelu MM; Flynn JT; Schechner RS; Pullman JM; Feuerstein D; Del Rio M
    Pediatr Transplant; 2005 Dec; 9(6):801-4. PubMed ID: 16269055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute anuric renal failure secondary to intravenous immunoglobulin in diabetic nephropathy.
    Biswas M; Evans PJ
    Diabetes Res Clin Pract; 2007 Apr; 76(1):139-41. PubMed ID: 16959362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute kidney failure secondary to intravenous immunoglobulin administration. 4 cases and review of the literature].
    Decocq G; de Cagny B; Andréjak M; Desablens B
    Therapie; 1996; 51(5):516-26. PubMed ID: 9138386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute renal failure after administration of intravenous immunoglobulin: review of the literature and case report.
    Winward DB; Brophy MT
    Pharmacotherapy; 1995; 15(6):765-72. PubMed ID: 8602385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reemergence of sucrose nephropathy: acute renal failure caused by high-dose intravenous immune globulin therapy.
    Zhang R; Szerlip HM
    South Med J; 2000 Sep; 93(9):901-4. PubMed ID: 11005352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemoglobinuria and acute kidney injury requiring hemodialysis following intravenous immunoglobulin infusion.
    Welles CC; Tambra S; Lafayette RA
    Am J Kidney Dis; 2010 Jan; 55(1):148-51. PubMed ID: 19628320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of intravenous immunoglobulin (IVIG) therapy.
    Katz U; Achiron A; Sherer Y; Shoenfeld Y
    Autoimmun Rev; 2007 Mar; 6(4):257-9. PubMed ID: 17317619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure to inhibitors of the renin-angiotensin system is a major independent risk factor for acute renal failure induced by sucrose-containing intravenous immunoglobulins: a case-control study.
    Moulis G; Sailler L; Sommet A; Lapeyre-Mestre M; Montastruc JL;
    Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):314-9. PubMed ID: 21953992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute renal failure after intravenous immunoglobulin therapy.
    Pasatiempo AM; Kroser JA; Rudnick M; Hoffman BI
    J Rheumatol; 1994 Feb; 21(2):347-9. PubMed ID: 8182648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of adverse events associated with intravenous immunoglobulin therapy in patients with pemphigus or pemphigoid.
    Gürcan HM; Ahmed AR
    Ann Pharmacother; 2007 Oct; 41(10):1604-10. PubMed ID: 17785614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case report: acute renal failure after administering intravenous immunoglobulin.
    Graumann A; Zawada ET
    Postgrad Med; 2010 Mar; 122(2):142-7. PubMed ID: 20203465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute ST elevation myocardial infarction during intravenous immunoglobulin infusion.
    Barsheshet A; Marai I; Appel S; Zimlichman E
    Ann N Y Acad Sci; 2007 Sep; 1110():315-8. PubMed ID: 17911446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous gammglobulin-associated acute renal failure.
    Gupta N; Ahmed I; Nissel-Horowitz S; Patel D; Mehrotra B
    Am J Hematol; 2001 Feb; 66(2):151-2. PubMed ID: 11421298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of intravenous immunoglobulin in the elderly treated for a dysimmune neuromuscular disease.
    Lozeron P; Not A; Theaudin M; Denier C; Masnou P; Sarov M; Adam C; Cauquil C; Adams D
    Muscle Nerve; 2016 May; 53(5):683-9. PubMed ID: 26467654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.